Pharmaceutical News

RSS

Lamaty employs Uniqsis FlowSyn Multi-X system to achieve efficient ring closing olefin metathesis

Uniqsis has published details of a new flow-through protocol developed by the Lamaty Group at Universite de Montpellier on a FlowSyn™ Multi-X system that provides efficient ring closing olefin metathesis.

10 May 2017

Swiss researchers discover potential way to design new antibiotics

Two Swiss research teams from the University of Bern and the ETH Zurich have developed a new method to shed light onto a mostly unknown process of bacterial protein production. Their results could be used for the design of new antibiotics.

10 May 2017

Natural compound in grape seed extract could increase strength, life of composite-resin fillings

A natural compound found in grape seed extract could be used to strengthen dentin -- the tissue beneath a tooth's enamel -- and increase the life of resin fillings, according to new research at the University of Illinois at Chicago College of Dentistry.

10 May 2017

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion, according to a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

10 May 2017

Scientists aim to revolutionize asthma treatment by replacing inhalers with new drug

A common treatment for asthma, which is the most prevalent chronic childhood disease, requires use of an inhaler. But a big problem with inhalers, used to deliver steroids and other drugs in an aerosol form, is that children often don't operate them properly.

10 May 2017

Three TSRI scientists receive awards from Royal Society of Chemistry

Three chemists from The Scripps Research Institute- Dale Boger, Jin-Quan Yu and Phil Baran- have received awards from the Royal Society of Chemistry, a renowned professional organization for chemists based in the United Kingdom, with more than 54,000 members worldwide.

10 May 2017

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Nearly one in two seniors in Ontario who visited a family doctor for a non-bacterial infection received an unnecessary antibiotic prescription, according to a new study from the Institute for Clinical Evaluative Sciences Western site in London, Ontario and Lawson Health Research Institute.

9 May 2017

Researchers find many postmarket safety events after FDA approval of new drugs

How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.

9 May 2017

BGRF scientists help develop AI to expedite drug development for age-related conditions

The Chief Science Officer of the Biogerontology Research Foundation will present new research on artificial intelligence for drug discovery at the NVIDIA Graphics Technology Conference at the San Jose Convention Center, on Wednesday, May 10, 1:00 PM - 1:50 PM alongside two AI scientists from the BGRF and Insilico Medicine, where they will deliver a presentation titled "Applications of Generative Adversarial Networks to Drug Discovery in Oncology and Infectious Diseases".

9 May 2017

Novel nanoscale molecular slingshot could ‘shoot’ and deliver drugs at precise disease locations

An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.

9 May 2017

PTSD and psychoactive drugs linked to increased risk for dementia

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia.

9 May 2017

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

8 May 2017

Drug used to treat bipolar disorder may help prevent brain cell damage in TBI patients

A drug used to treat bipolar disorder and other forms of depression may help to preserve brain function and prevent nerve cells from dying in people with a traumatic brain injury, according to a new Rutgers University study.

8 May 2017

WHO to launch pilot project for prequalifying biosimilar cancer medicines

This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries.

8 May 2017

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

8 May 2017

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

Although pain, memory and nicotine addiction may not seem to be related, they actually share a common player: the nicotinic acetylcholine receptors.

5 May 2017

FDA approves new treatment for people with ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.

5 May 2017

Experts find benefits of antipsychotic medications to be much greater than side effects

An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.

5 May 2017

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

A late breaking subanalysis of the phase III CONVERT trial presented at the European Lung Cancer Conference shows that white blood cell boosting drugs are safe during concurrent chemo-radiotherapy of small cell lung cancer (SCLC).

5 May 2017

Advancing safety in healthcare products

True benefit from healthcare products requires an unrelenting focus on patient- and consumer-centered safety, a principle that is at the heart of J&J’s Credo and is embodied in the mission of the Office of the Chief Medical Officer (OCMO).

From Johnson & Johnson 5 May 2017

Pharmaceutical News

Lamaty employs Uniqsis FlowSyn Multi-X system to achieve efficient ring closing olefin metathesis

Swiss researchers discover potential way to design new antibiotics

Natural compound in grape seed extract could increase strength, life of composite-resin fillings

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Scientists aim to revolutionize asthma treatment by replacing inhalers with new drug

Three TSRI scientists receive awards from Royal Society of Chemistry

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Researchers find many postmarket safety events after FDA approval of new drugs

BGRF scientists help develop AI to expedite drug development for age-related conditions

Novel nanoscale molecular slingshot could ‘shoot’ and deliver drugs at precise disease locations

PTSD and psychoactive drugs linked to increased risk for dementia

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Drug used to treat bipolar disorder may help prevent brain cell damage in TBI patients

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

FDA approves new treatment for people with ALS

Experts find benefits of antipsychotic medications to be much greater than side effects

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Advancing safety in healthcare products

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News